3,3-Diphenylpropylamine

3,3-Diphenylpropylamine is a form of diphenylpropylamine.

3,3-Diphenylpropylamine
Names
Preferred IUPAC name
3,3-Diphenylpropan-1-amine
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
ECHA InfoCard 100.024.532
UNII
  • InChI=1S/C15H17N/c16-12-11-15(13-7-3-1-4-8-13)14-9-5-2-6-10-14/h1-10,15H,11-12,16H2 checkY
    Key: KISZTEOELCMZPY-UHFFFAOYSA-N checkY
  • C1=CC=C(C=C1)C(CCN)C2=CC=CC=C2
Properties
C15H17N
Molar mass 211.308 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)
Infobox references

It is commonly conjugated to another agent giving a "bifunctional" molecule. Such agents are not infrequently used to treat Cardiovascular disease (CVD).

Further embellishment of the molecular structure can lead to an agent that is called Delucemine.

3,3-Diphenylpropylamine derivatives list table
NameIdentifierPicture
BIIA 0388CID:9958467 [337359-07-6]
BZP derivative[1]
Droprenilamine[57653-27-7]
Fendiline[13042-18-7]
Lercanidipine[100427-26-7]
KD-983[50597-65-4]
Mepramidil[23891-60-3]
Milverine[75437-14-8]
PF 244Fb: [52017-07-9]
Prenylamine[390-64-7]
SoRI-20041now SRI-20041
Tiopropamine[39516-21-7]
[117-34-0] [5586-73-2] amide:[2]

References

  1. Tadayuki Suzuki & Toshiharu Megumi, U.S. Patent 3,957,790 (1976 to Tokyo Tanabe Co Ltd).
  2. Urbani, P., Cascio, M. G., Ramunno, A., Bisogno, T., Saturnino, C., Marzo, V. D. (August 2008). "Novel sterically hindered cannabinoid CB1 receptor ligands". Bioorganic & Medicinal Chemistry. 16 (15): 7510–7515. doi:10.1016/j.bmc.2008.06.001.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.